6955 — Shandong Boan Biotechnology Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$5.69bn
- HK$6.21bn
- CNY726.32m
- 27
- 10
- 65
- 23
Annual cashflow statement for Shandong Boan Biotechnology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -241 | -225 | -332 | -119 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 10.6 | 28.8 | 23.6 | 36.4 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -293 | -99.7 | 33.4 | -18.3 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -507 | -246 | -202 | -18.6 | — |
| Capital Expenditures | -131 | -341 | -206 | -295 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 112 | -91.1 | 106 | 1.19 | — |
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -18.8 | -432 | -101 | -294 | — |
| Financing Cash Flow Items | 1,013 | 1,221 | -224 | 187 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 527 | 1,212 | -0.127 | 283 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.73 | 528 | -298 | -31.6 | — |